EUVIMEDEUVIMED entdecken
Crossref

Effectiveness of combined proton pump inhibitors and posaconazole prophylaxis against invasive fungal infections in patients with hematologic malignancies: a retrospective study

Yan Liu, Ruochen Qu, Yan Zhao, Ziyi Wang, Shizhao Yuan, Shuai Liu, Chunhua Zhou, Jing Yu

International Journal of Clinical Pharmacy · 2025

DOI: 10.1007/s11096-024-01841-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Clinical Pharmacy, 2025. Verfasst von Yan Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Pharmacy, The First Hospital of Hebei Medical University, Shijiazhuang, 050000, China. Hauptthemen laut MEDLINE: Proton Pump Inhibitors, Triazoles, Invasive Fungal Infections, Hematologic Neoplasms. Die Arbeit nennt 39 Literaturangaben. Gefördert von: Health Commission of Hebei Province, the Department of Finance of Hebei.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Posaconazole is widely recommended for preventing and treating invasive fungal infections (IFIs) in immunocompromised patients, especially those with prolonged neutropenia. However, the concentration of the oral suspension formulation can be affected by factors such as co-administration with acid-suppressing medications, influencing its efficacy and safety. AIM: This study examined the impact of proton pump inhibitors (PPIs) and other factors on posaconazole concentrations and the concentration-to-dose ratio (C/D) while also evaluating adverse drug reactions in patients with hematologic malignancies. METHOD: We conducted a retrospective analysis of patients who received posaconazole for IFI prophylaxis or treatment, assessing demographic and clinical data, adverse reactions, treatment outcomes, and drug concentration assays. The study focused on the effects of PPIs on Cmin and C/D. RESULTS: Data from 283 posaconazole Cmin measurements in 86 patients were analyzed. The incidence of probable or proven IFIs was 6.4% (5/78). PPI use reduced posaconazole Cmin levels but did not significantly impact prophylactic efficacy. Esomeprazole and rabeprazole were explicitly associated with decreased Cmin. Hepatotoxicity was linked to the co-administration of hepatotoxic drugs, indicating that posaconazole was not the sole contributor. CONCLUSION: Co-administration of esomeprazole or rabeprazole lowers posaconazole plasma concentrations without compromising prophylactic efficacy against IFIs. Nonetheless, caution is advised when combining these drugs in high-risk immunocompromised patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Proton Pump InhibitorsTriazolesInvasive Fungal InfectionsHematologic NeoplasmsAntifungal AgentsHumansRetrospective StudiesMaleFemaleMiddle AgedAgedAdultDrug Therapy, CombinationTreatment OutcomeImmunocompromised HostYoung AdultDrug InteractionsAged, 80 and over

Stichwörter der Autor:innen

Adverse drug reactionsInvasive fungal infectionsPosaconazoleProton pump inhibitors

Substanzen

posaconazoleProton Pump InhibitorsTriazolesAntifungal Agents

Autor:innen und Institutionen

  • Department of Clinical Pharmacy, The First Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
  • The Technology Innovation Center for Artificial Intelligence in Clinical Pharmacy of Hebei Province, The First Hospital of Hebei Medical University, Shijiazhuang, 050000, China.
  • Department of Clinical Pharmacy, The First Hospital of Hebei Medical University, Shijiazhuang, 050000, China. yujing@hebmu.edu.cn.
  • The Technology Innovation Center for Artificial Intelligence in Clinical Pharmacy of Hebei Province, The First Hospital of Hebei Medical University, Shijiazhuang, 050000, China. yujing@hebmu.edu.cn.

Förderung

  • Health Commission of Hebei Province
  • the Department of Finance of Hebei

Zitieren

APA

Liu, Y., Qu, R., Zhao, Y., Wang, Z., Yuan, S., Liu, S., Zhou, C., & Yu, J. (2025). Effectiveness of combined proton pump inhibitors and posaconazole prophylaxis against invasive fungal infections in patients with hematologic malignancies: a retrospective study. International Journal of Clinical Pharmacy. https://doi.org/10.1007/s11096-024-01841-8

Vancouver

Liu Y, Qu R, Zhao Y, Wang Z, Yuan S, Liu S, et al. Effectiveness of combined proton pump inhibitors and posaconazole prophylaxis against invasive fungal infections in patients with hematologic malignancies: a retrospective study. International Journal of Clinical Pharmacy. 2025. doi:10.1007/s11096-024-01841-8

BibTeX
@article{Liu2025,
  author = {Liu, Yan and Qu, Ruochen and Zhao, Yan and Wang, Ziyi and Yuan, Shizhao and Liu, Shuai and Zhou, Chunhua and Yu, Jing},
  title = {Effectiveness of combined proton pump inhibitors and posaconazole prophylaxis against invasive fungal infections in patients with hematologic malignancies: a retrospective study},
  journal = {International Journal of Clinical Pharmacy},
  year = {2025},
  doi = {10.1007/s11096-024-01841-8}
}
Kostenlos starten →